BENEO-Orafti (Morris Plains, NJ), a producer of inulin and oligofructose, will be exhibiting new findings on continuing research on consumer conscience in health and wellness at this year’s Health Ingredients Europe (HIE) show in France. Preliminary results will be announced from research conducted in the US and UK with other European findings being revealed at a later date.
BENEO-Orafti (Morris Plains, NJ), a producer of inulin and oligofructose, will be exhibiting new findings on continuing research on consumer conscience in health and wellness at this year’s Health Ingredients Europe (HIE) show in France. This is the 15th study they have commissioned in the past five years. Preliminary results will be announced from research conducted in the US and UK with other European findings being revealed at a later date. The study program examines knowledge and awareness levels of consumers on health concepts like 'the prebiotic effect' and 'digestive well-being.' It also sheds light on consumer’s understanding on satiety and calcium absorption claims.
Dominic Speleers, Managing Director of BENEO-Orafti, said, "This latest study is just another example of BENEO-Orafti's commitment to investing in consumer research to provide the highest possible level of support to our partners."
"Science, consumer understanding, applications know-how and regulatory expertise have always been key focuses for our business. This depth of knowledge is what allows us to effectively work in partnership with food manufacturers to successfully launch functional products into the marketplace. We invite existing and potential new partners to visit the BENEO-Orafti booth at HIE to allow us to share our know-how with them," he added.
Kelker Pharma to launch nutritional support system for GLP-1 medication users that features TriBsyn
December 11th 2024B&D Nutritional Ingredients Inc., an exclusive distribution partner of CarnoSyn Brands and Natural Alternatives International Inc., announced that its customer, Kelker Pharma, will be launching the “first science-backed nutritional support system” for GLP-1 medication users, called Nutrilinq Genesis.
Recent study compares the effectiveness of two probiotic products on colicky infants
October 31st 2024The study compared AB-Biotics and Kaneka Probiotics’ probiotic formulation of Bifidobacterium longum KABP®-042 and Pediococcus pentosaceus KABP®-041 to Lactobacillus reuteri DSM17938 (LR) from Biogaia.